PYC Therapeutics kicks off Phase 1b MAD for PKD with first patient dosed in PYC-003; data due CY27, paving the way to registrational Phase 2/3 and NDA. The MAD study aims to establish safety and ...

Abstract: Python has become the programming language of choice for research and industry projects related to data science, machine learning, and deep learning. Since optimization is an inherent part ...

Safety Review Committee greenlights progression of 60-microgram dose following positive safety and tolerability outcomes in Phase 1 trial. PYC Therapeutics Limited (ASX:PYC) today announced a ...

This raise will set the company up for years. With PYC's value sitting at $944.8 million at the close of trade on Friday, the raise will grow the size of the company by 69.2% in one fell swoop. The ...

PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised at $933 million on the ASX, confirmed a $653 million equity raising on Monday morning after Street Talk revealed the ...

Game decompilations have been in the news on and off again for quite some time. It’s the act of reverse engineering games to run natively on PC (or any hardware, in theory). Now, there’s potential for ...

A look at the shareholders of PYC Therapeutics Limited (ASX:PYC) can tell us which group is most powerful. The group holding the most number of shares in the company, around 45% to be precise, is ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

PYC Therapeutics has announced that Peter Coleman has been appointed non-executive chair, effective from the end of its annual general meeting on November 18. This announcement comes on the back of ...

Abstract: Decompiler is a specialized type of reverse engineering tool extensively employed in program analysis tasks, particularly in program comprehension and vulnerability detection. However, ...